Overview
Clinical Meaning
Cirrhosis is the end stage of chronic liver disease characterized by diffuse fibrosis, regenerative nodule formation, and distortion of hepatic architecture.
AGPCNP
AGPCNP
Cirrhosis is the end-stage of chronic liver disease characterized by diffuse fibrosis, regenerative nodule formation, and distortion of hepatic architecture. Chronic injury (alcohol, viral hepatitis, NAFLD/NASH) activates hepatic stellate cells, which transform from quiescent vitamin A-storing cells into myofibroblasts that produce excessive collagen (types I and III), forming fibrous septa that disrupt normal lobular architecture. This creates portosystemic shunting, impaired hepatocyte function, and portal hypertension (hepatic venous pressure gradient >5 mmHg; clinically significant >10 mmHg). Consequences include synthetic failure (hypoalbuminemia, coagulopathy), impaired detoxification (hyperammonemia → hepatic encephalopathy), and portal hypertension complications (varices, ascites, splenomegaly).
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Final rapid review before practice
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this AGPCNP pathway. You can still explore topic-filtered questions from the bank hubs below.